TheStreet

Log In

Receive full access to our market insights, commentary, newsletters, breaking news alerts, and more.
Forgot your password?Don't have an account? Sign Up Here

Join Us

Receive full access to our market insights, commentary, newsletters, breaking news alerts, and more.
Already have an account? Login here
TheStreet
JIM CRAMERINVESTINGPERSONAL FINANCERETIREMENTTECHNOLOGYMARKETSHOW-TOVIDEOFINANCIAL ADVISOR CENTER
Search

Trade with Jim Cramer 14 Days Free

Join the Action Alerts PLUS Community today!

SUBSCRIBE NOW

LATEST NEWS

Otonomy Shares Rebound After Wednesday's Drop- Biotech Movers
STOCKS

Axovant Rises After Tuesday's Plunge - Biotech Movers

  • By Armie Margaret Lee
  • Sep 27, 2017 9:46 AM EDT
Mylan Falls on FDA Warning on Quality Control
HEALTH

These Two Biotech Stocks Are Going Berserk on Wednesday

  • By Armie Margaret Lee
  • Aug 9, 2017 11:59 AM EDT
Biotech Premarket Movers: Cempra, Tesaro, Editas
HEALTH

Biotech Premarket Movers: Cempra, Tesaro, Editas

  • By Armie Margaret Lee
  • Mar 28, 2017 9:23 AM EDT
Mallinckrodt Spikes on Positive Regenerative Tissue Treatment Results
HEALTH

Biotech Premarket Movers: Cempra, Blueprint Medicines, Aralez

  • By Armie Margaret Lee
  • Mar 13, 2017 9:32 AM EDT
Mesoblast Soars on Stem-Cell Treatment Data
HEALTH

Biotech Premarket Movers: Cempra, Novavax, Ionis

  • By Armie Margaret Lee
  • Feb 28, 2017 9:22 AM EST
Biotech Movers: Lion Biotechnologies, XBiotech, Halozyme
HEALTH

Biotech premarket movers: Biocryst, Sangamo, Cempra

  • By Armie Margaret Lee
  • Feb 27, 2017 9:09 AM EST
4 Biotech Stocks on the Move
VIDEO

4 Biotech Stocks on the Move

  • By TheStreet Staff
  • Feb 24, 2017 11:40 AM EST
Incyte Cancer Immunotherapy Drug Is Object of Desire for Two Big Pharma Rivals
STOCKS

Biotech Movers: Cempra flys high on phase three results

  • By Alicia McElhaney
  • Feb 24, 2017 9:38 AM EST
Regeneron stock
STOCKS

Acorda, Amgen and Regeneron lead premarket biotech movers

  • By Alicia McElhaney
  • Feb 9, 2017 9:05 AM EST
TheStreet's Guide to Trading in February
MARKETS

Wall Street Falls as Financial Stocks Lead the Decline

  • By Valerie Young
  • Dec 29, 2016 4:08 PM EST
Embrace the Risks of Picking a Winner: Cramer's 'Mad Money' Recap (Thursday 2/2/17)
MARKETS

Wall Street Slumps As Financial Stocks Lead the Decline

  • By Valerie Young
  • Dec 29, 2016 2:55 PM EST
Midday Report: Volatile Stocks Turn Negative; Cempra Plummets, Sears Soars
VIDEO

Midday Report: Stocks Volatile Turning Negative; Cempra Plummets, Sears Soars

  • By Valerie Young
  • Dec 29, 2016 12:02 PM EST
How to Make an Impact with Your Investments as You Age
MARKETS

Stocks volatile after trade deficit data; oil inventories rise

  • By Valerie Young
  • Dec 29, 2016 11:26 AM EST
Snap, Vail Resorts, Raymond James: 'Mad Money' Lightning Round
JIM CRAMER

'Mad Money' Lightning Round: Jim Cramer Sees Steel Companies Shining

  • By Scott Rutt
  • Nov 23, 2016 6:00 AM EST
Cramer's 'Mad Money' Recap (Tuesday 1/3/17): Better Buying Opportunities Are Lurking
JIM CRAMER

Jim Cramer's 'Mad Money' Recap: Expect More Earnings Surprises

  • By Scott Rutt
  • Nov 22, 2016 8:22 PM EST
Cempra Antibiotic Approval Still in Doubt Even With Positive FDA Panel Vote
STOCKS

Cempra antibiotic approval still in doubt even with positive fda panel vote

  • By Adam Feuerstein
  • Nov 7, 2016 9:59 AM EST
Cempra Antibiotic Approval Still in Doubt Even With Positive FDA Panel Vote
MARKETS

Cempra (CEMP) Stock Downgraded at JPMorgan on FDA Pneumonia Drug Review

  • By Annie Palmer
  • Nov 3, 2016 3:33 PM EDT
'Mad Money' Lightning Round: J.C. Penney Is 'A Lot Better,' Jim Cramer Says
JIM CRAMER

'Mad Money' lightning round: J.C. Penney is 'a lot better,' Jim Cramer says

  • By Scott Rutt
  • Nov 3, 2016 6:00 AM EDT
Jim Cramer's 'Mad Money' Recap: It's Chicago Versus Cleveland -- Stocks, That Is
JIM CRAMER

Jim Cramer's 'Mad Money' Recap: It's Chicago Versus Cleveland -- Stocks, That Is

  • By Scott Rutt
  • Nov 2, 2016 8:29 PM EDT
Global Blood Therapeutics Stock Surging on Nordisk Bid Speculation
STOCKS

These 5 biotech stocks are ready for a volatility break

  • By Robert Moreno
  • Sep 14, 2016 6:17 AM EDT
Today's Pre-Market Mover With Heavy Volume: Physicians Realty (DOC)
MARKETS

Perilous Reversal Watch: Cempra (CEMP)

  • By TheStreet Wire
  • Aug 8, 2016 3:22 PM EDT
Insider Trading Alert - DUK, STFC And RGLS Traded By Insiders
MARKETS

Cempra (CEMP) Is Today's Strong On High Volume Stock

  • By TheStreet Wire
  • Aug 1, 2016 10:05 AM EDT
Trump Expected to Name Scott Gottlieb as FDA Commissioner
OPINION

Antibiotic for treatment of superbugs could send Cempra shares soaring

  • By Rick Pearson
  • Jul 14, 2016 9:50 AM EDT
Today's Weak On High Volume Stock: Primero Mining (PPP)
MARKETS

Cempra (CEMP) Is Today's Strong On High Volume Stock

  • By TheStreet Wire
  • Jul 12, 2016 10:02 AM EDT
Barbarian At The Gate: Annaly Capital Management (NLY)
MARKETS

Strong On High Volume: Cempra (CEMP)

  • By TheStreet Wire
  • Jun 13, 2016 10:04 AM EDT
TheStreet
  • Terms Of Use
  • Privacy Policy
  • Advertise
  • Reprints
  • Customer Service
  • Data
  • Topic Archive
  • Subscriptions
© 2021 TheStreet, Inc. All rights reserved. Action Alerts PLUS is a registered trademark of TheStreet, Inc.